Royeck, Svenja
Funding for this research was provided by:
Universitätsklinikum Münster
Article History
Received: 24 March 2025
Accepted: 19 April 2025
First Online: 5 August 2025
Conflict of interest
: S. Royeck has worked as a consultant, speaker and/or auditor for Incyte Inc, Eli Lilly, LEO Pharma and Sanofi/Regeneron.